Search for: "Adolor"
Adolor Corporation Announces Restructuring
HSMN NewsFeed,
15 Jul 2010:
Biopharmaceuticals
[Adolor]
|
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
HSMN NewsFeed,
5 May 2010:
Biopharmaceuticals, Personnel
[FoldRx Pharmaceuticals, tafamidis]
|
Adolor Corporation Announces Management Appointments
HSMN NewsFeed,
14 Jan 2010:
Biopharmaceuticals, Personnel
[Adolor]
|
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
HSMN NewsFeed,
8 Jul 2009:
Biopharmaceuticals, Personnel
[Dicerna Pharmaceuticals]
|
Adolor Corporation Announces Management Appointments
HSMN NewsFeed,
7 Jan 2009:
Biopharmaceuticals, Personnel
[Adolor]
|
Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary
HSMN NewsFeed,
10 Sep 2008:
Biopharmaceuticals, Personnel
[Adolor]
|
Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
HSMN NewsFeed,
2 Sep 2008:
Biopharmaceuticals
[Adolor, GlaxoSmithKline, Entereg, alvimopan, chronic opioid bowel dysfunction]
|
Agios Pharmaceuticals Closes $33 Million Series A Funding
HSMN NewsFeed,
7 Jul 2008:
Biopharmaceuticals, Oncology, Venture Capital
[Agios Pharmaceuticals, Third Rock Ventures]
|
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, FDA
[Adolor, Entereg, alvimopan, opioid bowel dysfunction]
|
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director
HSMN NewsFeed,
2 Jun 2008:
Biopharmaceuticals, Personnel
[Adolor]
|
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
HSMN NewsFeed,
20 May 2008:
Biopharmaceuticals, FDA
[Adolor, GlaxoSmithKline, Entereg, alvimopan, Postoperative ileus]
|
Adolor Provides Regulatory Update on Entereg(R) (alvimopan)
HSMN NewsFeed,
9 May 2008:
Biopharmaceuticals
[Adolor, Entereg, alvimopan, postoperative ileus]
|
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
HSMN NewsFeed,
3 Apr 2008:
Biopharmaceuticals, Personnel
[Alba Therapeutics]
|
Acura Pharmaceuticals, Inc. Names Robert B. Jones Chief Operating Officer
HSMN NewsFeed,
24 Mar 2008:
Biopharmaceuticals, Personnel
[Acura Pharmaceuticals]
|
FDA Extends Review of NDA for ENTEREG(R) (alvimopan)
HSMN NewsFeed,
8 Feb 2008:
Biopharmaceuticals, FDA
[Adolor, GlaxoSmithKline, ENTEREG, alvimopan]
|
Adolor and GlaxoSmithKline Report Favorable FDA Advisory Committee Meeting for ENTEREG(R) (alvimopan) for the Management of Postoperative Ileus in Bowel Resection
HSMN NewsFeed,
23 Jan 2008:
Biopharmaceuticals
[Adolor, GlaxoSmithKline, Entereg, alvimopan, postoperative ileus]
|
Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals
[Pfizer, Adolor, ADL5859, ADL5747]
|
Adolor and GlaxoSmithKline Announce FDA Advisory Committee to Review Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
HSMN NewsFeed,
28 Nov 2007:
Biopharmaceuticals, Surgery
[Adolor, GlaxoSmithKline, Entereg, alvimopan, Postoperative Ileus]
|
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
HSMN NewsFeed,
13 Sep 2007:
Biopharmaceuticals, FDA
[Adolor, GlaxoSmithKline, Entereg, alvimopan, postoperative ileus]
|
NeurogesX Appoints New Director to the Board
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Personnel
[NeurogesX]
|
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
HSMN NewsFeed,
28 Aug 2007:
Biopharmaceuticals, Surgery, FDA
[Adolor, GlaxoSmithKline, Entereg, alvimopan, postoperative ileus]
|
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
HSMN NewsFeed,
11 Jun 2007:
Biopharmaceuticals
[Adolor, GlaxoSmithKline, alvimopan, Entereg, Entrareg]
|
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
HSMN NewsFeed,
9 Apr 2007:
Biopharmaceuticals
[GlaxoSmithKline, Adolor, Entereg, Entrareg, alvimopan]
|
Adolor Elects Michael R. Dougherty Chief Executive Officer
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals, Personnel
[Adolor, Entereg, alvimopan, postoperative ileus]
|
Adolor Announces Discontinuation of Sales Force and Other Selected Work Force Reductions
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals
[Adolor, Entereg, alvimopan, postoperative ileus]
|
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
HSMN NewsFeed,
30 Nov 2006:
Biopharmaceuticals, Venture Capital
[Concert Pharmaceuticals]
|
FDA Issues Approvable Letter for Entereg(R) (alvimopan) for POI
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, FDA
[Adolor, GlaxoSmithKline, Entereg, alvimopan, postoperative ileus]
|
EpiCept Regains North American Rights to LidoPAIN(R) SP
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Drug Delivery
[EpiCept, Adolor, LidoPAIN SP, lidocaine patch]
|
Adolor Corporation Discontinues Development of Sterile Lidocaine Patch
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Drug Delivery
[Adolor, EpiCept, lidocaine patch]
|
GlaxoSmithKline and Adolor Report Top-Line Results From Phase 3 Studies of Alvimopan (Entereg/Entrareg(R))
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals
[Adolor, GlaxoSmithKline, alvimopan, Entereg, Entrareg]
|
Sapphire Therapeutics, Inc. Expands Drug Development Team
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
HSMN NewsFeed,
28 Jun 2006:
Biopharmaceuticals, Personnel
[Adolor]
|
Auxilium Appoints Armando Anido as Chief Executive Officer and President
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals, Personnel
[Auxilium Pharmaceuticals]
|
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
HSMN NewsFeed,
31 May 2006:
Biopharmaceuticals, Gastroenterology, Surgery, FDA
[Adolor, GlaxoSmithKline, Entereg , post-operative ileus]
|
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals
[GlaxoSmithKline, Adolor, Entereg, Alvimopan]
|
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
HSMN NewsFeed,
3 May 2006:
Biopharmaceuticals, Personnel
[Othera Pharmaceuticals]
|
GlaxoSmithKline and Adolor Announce the Completion of Enrollment of Pivotal Clinical Studies of Entereg(R) (Alvimopan)
HSMN NewsFeed,
13 Apr 2006:
Biopharmaceuticals
[Adolor, GlaxoSmithKline, Entereg, alvimopan]
|
EpiCept Corporation Completes Merger With Maxim Pharmaceuticals
HSMN NewsFeed,
4 Jan 2006:
Biopharmaceuticals, Mergers & Acquisitions
[EpiCept, Maxim Pharmaceuticals]
|
|
|
Public
Feeds 
Full text >>
